About Us

About Us

We are a team of architects, engineers, scientists.
We believe in science and in service to the others.
We value science through our engagement on creating lab workplace solution and funding support, so that life science companies can focus their time, investment and energy on science.
We are enthusiastic to innovative our work as much as scientists to their discovery!

Our board

Zhang Xi

Chairman | CEO
Zhang Xi graduated with a Masters degree from ETH Zürich in 2006, CEO of EXH Design in Shanghai and Zurich. After completed various large scale laboratories projects for pharma companies in Europe and China, she founded Superlab Suisse AG in 2019 in Zurich, Switzerland.

Dr. Thilo Schröder

Board Member
Thilo Schroeder, Ph.D. has a passion for precision medicines in cancer with a focus on identifying first and best-in-class targeted therapies regardless of drug modality. Since 2012, Thilo has helped grow and shape Nextech as a leading oncology focused venture firm.
Thilo is a board member of Revolution Medicines (NASDAQ: RVMD), PMV Pharma (NASDAQ: PVMP), Circle Pharma, Silverback Therapeutics (NASDAQ: SBTX), MOMA Therapeutics. Past board seats include Blueprint Medicines (NASDAQ: BPMC), Peloton Therapeutics (acquired by Merck) and IDEAYA Biosciences (NASDAQ: IDYA). Thilo is a past board observer of BlackDiamond Therapeutics (NASDAQ: BDTX).
Thilo began his biotech career at the pioneering cancer immunology company Micromet (acquired by Amgen) while studying at Ecole Supérieure de Biotechnologie de Strasbourg, conducted research at the University of Sydney and obtained his Ph.D. from the University of Zurich, focused on protein engineering in the development of Designed Ankyrin Repeat Proteins (DARPins), a technology developed by Molecular Partners (SWX:MOLN).

Dr. Marcel Kucher

Board Member
Marcel Kucher is the Chief Financial Officer of Swiss Prime Site AG since 1 July 2021. He graduated in economics at the University of Zurich in 2000 with a dissertation before starting his professional career at McKinsey & Company. From 2004 to 2011, he was CFO and Head Corporate Development at the recruitment company a-connect. From 2011 to mid-2021 he was with the listed Peach Property Group, from 2012 as CFO and from 2015 additionally as COO.

Our management

Mika Bots

Chief Business Officer
Mika Bots, Chief Business Officer at Superlab Suisse, holds a master's degree in Aerospace Engineering from Delft University of Technology, and has a strong background in private equity and strategy consulting. With his result-driven approach, Mika blends his analytical skills from his engineering background with an assertive attitude, excelling in team settings and engaging both internal and external stakeholders. Passionate about technology and innovation, Mika constantly strives for excellence and leads the company to business success.

Johannes Boghaert

CEO Office Lead
Johannes joined Superlab Suisse as the CEO office lead, he graduated at Harvard University, where he was a John A. Paulson SEAS Fellow. He also holds an MSc in Mechanical Engineering from ETH Zurich. Johannes has experience in venture capital, advising growth and private equity teams, and engineering roles. He also founded and led multiple organizations, including Belgian Association for Students in Switzerland and 180 Degrees Consulting Delft.

Our Lab Operation

Areege Azmi

Lab manager Lausanne
As an accomplished Lab Manager, Areege has five years of extensive hands-on experience in R&D laboratory settings, with a focus on microbiology and molecular biology. During her time at Roche and previous employments, she has been actively doing lab management tasks while carrying out experiments in the BSL-2 laboratories.

Our Partners